What Is Biofrontera Inc. (BFRI) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on Biofrontera Inc. at $1.09. With an estimated intrinsic value of $2.30 and 6 of 9 models pointing higher, the average implied return is +111.4%. The most optimistic model, First Chicago, places fair value at $6.21 (+470.0%), while ML-RIV — the most conservative — estimates $0.08 (-92.5%). This +562.5% gap reflects genuine analytical uncertainty about Biofrontera Inc.'s intrinsic worth.
What Do the Models Say About BFRI?
9 of 13 models are currently active for BFRI. Of these, 6 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates BFRI's intrinsic value at $0.44, implying -59.7% downside from the current price. See which stocks rank higher →
How Does BFRI Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, BFRI ranks #183 by Quality of Company score. CirclFi's QOC score of 5.2/10 evaluates 32 fundamental signals. A score of 5.2 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a pharmaceutical industry, Biofrontera Inc. operates in a sector where biosimilar competition timeline is a critical driver of valuation. Investors evaluating BFRI should weigh these sector-specific dynamics alongside our model-derived fair values.
Is BFRI a Value Trap?
CirclFi's Value Trap algorithm assigns BFRI a score of 36/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Biofrontera Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Biofrontera Inc.'s fundamental quality profile registers 5.2/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +562.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BFRI valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BFRI's 9 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad